Previous Article | Next Article ![]()
Journal of Bacteriology, August 2003, p. 4371-4381, Vol. 185, No. 15
0021-9193/03/$08.00+0 DOI: 10.1128/JB.185.15.4371-4381.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Max-Planck-Institut für Molekulare Genetik, Abteilung Lehrach, Dahlem, D-14195 Berlin, Germany
Received 4 April 2003/ Accepted 30 April 2003
|
|
|---|
2 and TrwB
1) and/or containing a point mutation at the putative nucleotide-binding site (TraG
2K187T and TraGK187T). Unlike TraG and TrwB, truncated derivatives behaved as monomers without the tendency to form oligomers or aggregates. Surface plasmon resonance analysis with immobilized relaxase showed that mutant TraGK187T was as good a binding partner as the wild-type protein, whereas truncated TraG monomers were unable to bind relaxase. TraG
2 and TrwB
1 bound ATP and, with similar affinity, ADP. Binding of ATP and ADP was strongly inhibited by the presence of Mg2+ or single-stranded DNA and was competed for by other nucleotides. Compared to the activity of TraG
2, the ATP- and ADP-binding activity of the point mutation derivative TraG
2K187T was significantly reduced. Each TraG derivative bound DNA with an affinity similar to that of the native protein. DNA binding was inhibited or competed for by ATP, ADP, and, most prominently, Mg2+. Thus, both nucleotide binding and DNA binding were sensitive to Mg2+ and were competitive with respect to each other. |
|
|---|
A set of genes is conserved among type IV secretion systems (T4SS). Most of these genes are responsible for the formation of a membrane-spanning protein complex and for biosynthesis of a pilus (8). In bacterial conjugation systems the pilus acts as a sex pilus that is required for initial attachment to recipient cells, followed by mating pair formation and DNA transfer (45). An additional component conserved among T4SS is the TraG-like protein (coupling protein). TraG is a putative nucleoside triphosphatase (NTPase) that may serve as the active motor for secretion. It forms a membrane-anchored oligomer (1, 22, 38), which binds to DNA nonspecifically (27, 29, 38) and is involved in recognition of the substrate to be secreted (10, 38). In the case of the conjugative plasmid RP4, this substrate consists of the plasmid-encoded protein relaxase (TraI) that is covalently attached to the linearized transfer DNA strand of the plasmid (32). The cytoplasmic domain of the TraG-like protein of plasmid R388, TrwB
N70, has a hexameric pore-like structure that probably extends into the membrane (13), indicating that TraG-like proteins may serve as a gate through the inner membrane. In vitro studies with purified TraG-like proteins TrwB (R388), TraG (RP4), TraD (F), and HP0524 (H. pylori) failed to confirm the postulated NTPase activity (27, 38). However, it was demonstrated that TrwB binds ATP (16, 27).
In the present work, the nucleotide-binding properties of TraG and TrwB were studied in detail and the multiple activities of TraG and TrwB were dissected structurally and functionally. To this end, deletion mutation and point mutation derivatives were purified and biochemically characterized. Apart from binding DNA and ATP, the cytoplasmic domains of TraG and of TrwB were also found to bind ADP. DNA binding and nucleotide binding were competitive with each other and were both inhibited by Mg2+. Other nucleotides (GTP, CTP, UTP, and dTTP) were shown to be effective in competing for ATP binding. A point mutation at conserved residue K187 of the proposed P-loop motif (Walker A motif) of TraG caused a significant decrease in nucleotide-binding ability. Removal of the membrane anchor of TraG and TrwB prevented oligomerization or aggregation. Furthermore, the affinity of TraG for relaxase (TraI) was lost.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Plasmids used in this study
|
-thio)-triphosphate, sodium salt (ATP
S) and adenosine-5-[(ß,
)-imido]triphosphate, triethylammonium salt (AppNp) (Jena Bioscience), enzymes (New England Biolabs), and Brij 58 and Triton X-100 (Sigma). Buffers. The following buffers were used: buffer A (100 mM Tris-HCl [pH 7.6], 40 mM NaCl, 8% [wt/vol] sucrose, 0.4 mg of lysozyme/ml, 0.15% Brij 58), buffer B (100 mM Tris-HCl [pH 7.6], 100 mM NaCl, 0.25% Brij 58), buffer C (50 mM KH2PO4-K2HPO4 [pH 8.0], 300 mM NaCl, 1 mM dithiothreitol [DTT]), buffer D (50 mM Tris-H3PO4 [pH 7.0], 40 mM NaCl, 1 mM DTT), buffer E (40 mM Tris-HCl [pH 7.6], 50 mM NaCl, 1 mM DTT, 0.1 mM EDTA), buffer F (50 mM Tris-HCl [pH 7.6], 500 mM NaCl, 1 mM DTT, 0.1 mM EDTA, 10% [wt/vol] glycerol, 0.01% Brij 58), buffer G (20 mM Tris-HCl [pH 7.6], 10 mM NaCl, 1 mM DTT, 0.05% Brij 58, 50 µg of bovine serum albumin [BSA]/ml), and buffer H (40 mM Tris-HCl [pH 8.7]-20 mM NaCl).
DNA techniques.
Standard molecular cloning techniques were performed as described previously (36). pGS002, a vector for construction and overexpression of His6-tagged genes, was generated as follows. pMS470
8 was digested with NdeI, and the resulting 5' overhangs were removed by using mung bean nuclease. The plasmid was then digested with HindIII and ligated with a His6 linker, which was prepared by annealing of oligonucleotides CATGCACCATCACCATCACCATATGGGCATGCA and AAGCTTGCATGCCCATATGGTGATGGTGATGGTGCATG. pGS003
1 was constructed by insertion of an NdeI/NsiI/BclI/HindIII/SacI linker (annealed oligonucleotides TATGCATCCGTCTGATCAAGCTTGTCCATGAGCTCATCACCATCACCATCACTGAT and AGCTATCAGTGATGGTGATGGTGATGAGCTCATGGACAAGCTTGATCAGACGGATGCA) into pMS470
8 (NdeI/HindIII). This was followed by deletion of an 18-bp EcoRI-SmaI fragment by consecutive restriction, removal of 5' overhangs (using mung bean nuclease), and religation. RP4 traG deletion derivatives his6-traG
1 and his6-traG
2 in pGS006
1 and pGS006
2 were generated by PCR using pSK470 as a template. Forward primers were CGTTCGAGCATATGACCGCGACGCAATATTTCGCCC and GCCGTCACGCATATGGTCAAGGC (nucleotides corresponding to the RP4 sequence are italicized, deviations from the original sequence are boldfaced, and the introduced NdeI site is underlined), and the reverse primer in both reactions was CTGTTTTATCAGACCGCTTCTGCG. pFS241M was generated by PCR with pBS140(K187T) (2) as the template and primers GCATTCCCATATGCACCATCACCATCACCATAAGAACCGAAACAACG and GCCTACGAAGCTTGGTGAGGCGCTGGAAGC. pGS007 was prepared by ligation of a 1,617-bp NsiI fragment of pSU4054 (4) into pGS003
1. The R388 trwB deletion derivative his6-trwB
1 in pGS012
1 was generated by PCR with pGS007 as the template, primer GTTGTTTGTCTGGCATATGAATAGCGTCG (nucleotides corresponding to the R388 sequence are italicized), and the same reverse primer as that used for pGS006
1. PCR fragments were generated with DeepVent DNA polymerase (New England Biolabs). Nucleotide sequences of PCR fragments were verified.
Conjugations.
Mating experiments to determine transfer frequencies of RP4-mediated conjugation were carried out on filters (2). HB101 cells carrying pDB127 (TraG-) plus pSK470 (TraG+), pGS006
1 (His6-TraG
1+), or pGS006
2 (his6-traG
2+) served as donors, and HB101 Nxr was used as a recipient.
Protein purification.
For overproduction, broth cultures of the indicated E. coli strains were grown at 30°C. Isopropyl-ß-D-thiogalactopyranoside (IPTG)-mediated induction of expression and harvesting, resuspension, and freezing of cells were performed as described previously (19). Further steps were carried out at 4°C or on ice unless otherwise noted. RP4 His6-TraG and TraI were purified as described previously (30, 38). His6-TraGK187T was purified from SCS1(pFS241M) in analogy to His6-TraG. His6-TraG
2 was purified as follows. SCS1(pGS006
2) cells (19.7 g, resuspended in 100 ml of 200 mM Tris [pH 7.6]-20 mM spermidine-HCl-2 mM EDTA) were thawed, supplemented with 200 ml of buffer A, and stirred for 90 min at room temperature. After centrifugation at 100,000 x g for 45 min, the supernatant was kept and the pellet was resuspended in 100 ml of buffer B by using a Dounce homogenizer. The suspension was centrifuged as before, and the supernatants of the two centrifugation steps were combined. Proteins were precipitated by addition of 147 g of (NH4)2SO4 (60% saturation), collected by centrifugation at 25,000 x g for 30 min, and resuspended in 35 ml of buffer C (fraction I, 35 ml). Fraction I was dialyzed against buffer C and applied to a Ni-NTA column. The column was washed with buffer C alone and with buffer C containing 10% (vol/vol) glycerol and 20 mM imidazole (pH 7.6). Proteins were eluted with buffer C containing 250 mM imidazole (pH 7.6). Fractions containing His6-TraG
2 were pooled (fraction II, 97 ml), dialyzed against buffer D, and applied to a phosphocellulose P11 column. Adsorbed proteins were eluted with a linear gradient (40 to 600 mM NaCl) in buffer D. His6-TraG
2-containing fractions were pooled and concentrated by dialysis against buffer E containing 20% (wt/vol) polyethylene glycol 20000 (fraction III, 17.5 ml). His6-TraG
2K187T was purified from SCS1(pGS011) by following the protocol used for TraG
2, starting with 19.1 g of cells in 100 ml of buffer. Purification of His6-TrwB
1 from SCS1(pGS012
1) was done similarly with 16.4 g of cells in 80 ml of buffer, except that the NaCl concentration in buffer A and buffer B was 1 M. Protein purity and concentrations were determined by laser densitometric quantification of Coomassie blue (Serva)-stained gels with serial concentrations of BSA as a reference, by using the Personal Densitometer scanning device (Amersham Biosciences) and ImageQuant software (version 5.0). The identity of TraG derivatives was confirmed by Western blot analysis with a TraG-specific antiserum (46). Purified proteins were stored at -20°C in buffer E containing 50% (wt/vol) glycerol.
Gel filtration.
A Superdex 200 HR 10/30 column was calibrated with a gel filtration standard (Bio-Rad) consisting of four globular proteins of 670, 158, 44, and 17 kDa and vitamin B12 (1.4 kDa). The column was run with buffer F at a flow rate of 0.4 ml/min. Protein elution was monitored at a
of 280 nm. TraG, TraG
2, and TrwB
1 were subjected to gel filtration under the same conditions. A trend line correlating the elution volumes of the gel filtration standards to the corresponding Mrs was used to obtain estimates of the Mrs of TraG, TraG
2, and TrwB
1.
Fragment retardation assay.
A 773-bp AccI-AvaI DNA fragment of pBR329 (Table 1) was 5' labeled with [
-32P]ATP by using T4 polynucleotide kinase. Thirty-six femtomoles of the labeled fragment was incubated for 30 min at 37°C with different amounts of TraG
2 (1 to 5 pmol) or TrwB
1 (0.5 to 3 pmol) in a total volume of 20 µl of buffer G. Samples were electrophoresed on nondenaturing polyacrylamide gels as described previously (47). The 32P-labeled DNA was visualized by the storage phosphor technology and analyzed with ImageQuant software (Molecular Dynamics). Complex formation between protein and DNA was determined by monitoring the decrease in the amount of free DNA. The amount of free DNA in each lane was quantified with reference to the amount of free DNA present in the absence of protein. Competition or inhibition of DNA binding by single-stranded DNA (ssDNA), Mg2+, ATP, or ADP was analyzed by quantifying the displacement of bound double-stranded DNA (dsDNA) fragments from dsDNA-protein complexes. Seventy-five femtomoles of 32P-labeled DNA fragments obtained by DraI/AccI restriction of pJF143 (Table 1) was incubated as before with 10 pmol of TraG
2 or 3 pmol of TrwB
1. After 10 min, MgCl2, ATP, ADP, or ssDNA was added as appropriate, and mixtures were incubated for another 20 min at 37°C and electrophoresed as before. The bound and free DNA fragments were visualized and quantified as before, and the fraction of free DNA versus total DNA was calculated to determine the percentage of complex resolution.
Transmission electron microscopy.
dsDNA (25 fmol of pJF143 digested with EcoRI and BamHI) and/or ssDNA (25 fmol of M13 mp18) was incubated for 10 min at room temperature with TraG or TraG
2 (0.48 pmol each). Following fixation with 0.2% (wt/vol) glutaraldehyde for 10 min, the samples were prepared for electron microscopy (with a Philips EM400) by adsorption to mica as described previously (39).
Nucleotide binding.
The fluorescent nucleotide analogues TNP-ATP and TNP-ADP were used to study nucleotide-binding. Proteins and nucleotides were diluted in buffer H in a total volume of 400 µl. Final concentrations of NaCl were adjusted to 36 mM (for TraG
2 and TraG
2K187T) or 50 mM (for TrwB
1). Mixtures were incubated for 20 s before measurement. Fluorescence spectra were taken at room temperature by using a Shimadzu RF-5000 spectrofluorometer with excitation at 410 nm and emission scanning in the range of 470 to 620 nm. The fluorescence maxima were determined graphically. For determination of Kd, 7 µM protein solutions were titrated with TNP-ATP or TNP-ADP. The Kd values of unlabeled ATP and ADP, as well as the inhibition constant of Mg2+, were determined by displacement of protein-bound TNP-nucleotides. Seven-micromolar protein solutions were incubated for 20 s with 50 µM TNP-ATP or 70 µM TNP-ADP (50 µM TNP-ADP in the case of TrwB
1). ATP, ADP, or MgCl2 (from 0.5 or 0.1 M stock solutions in buffer H) was added, and fluorescence was measured after incubation for 20 s.
Enhanced fluorescence (
F) was calculated as the difference between total fluorescence (Ft) and the intrinsic fluorescence of TNP-nucleotides (TNP-N), buffer, and proteins:
![]() | (1) |
F represents the amount of receptor-ligand complexes (RL) that are formed throughout the titration.
F reaches a maximum (
Fmax) as the receptor becomes saturated, i.e., when RL equals the total receptor concentration (Rt):
![]() | (2) |
![]() | (3) |
![]() | (4) |
Fmax and
Fmin are the fluorescences at the start and at the end of titration, respectively, and L is the concentration of the competitor (ATP, ADP, or Mg2+). IC50 represents the concentration of the competitor necessary to displace 50% of bound TNP-nucleotides. It is related to the inhibition constant (Ki) of the competitor (6) as follows:
![]() | (5) |
Protein interaction analysis by surface plasmon resonance (SPR).
Interactions between TraI and either TraG, TraGK187T, or TraG
2 were studied by using the Biacore 2000 optical biosensor system (Biacore AB, Uppsala, Sweden) with a B1 pioneer sensor chip as described previously (38). The chip was loaded with 480 response units (RU) of BSA (FC2), 498 RU of TraI (FC3), and 460 RU of TraG
2 (FC4). Dilutions were made in HBS-EP buffer (Biacore AB). For real-time analysis of interaction with the immobilized proteins, 100 nM solutions of TraGK187T or TraG
2 were injected into the chip (FC1, -2, -3, and -4). Signals were corrected for nonspecific binding by subtracting curves for BSA interaction from each curve. Binding constants were determined with the BIAevaluation software (version 3.1, copyright 1994 to 1999, Biacore AB), by applying the Langmuir binding model for computational fitting.
|
|
|---|
1 and TraG
2, lacking the first 36 or the first 102 residues of TraG, respectively, were constructed (Fig. 1). TraG
1 lacks the short cytoplasmic N terminus and the first of two transmembrane domains of TraG. In TraG
2, the periplasmic domain and the second transmembrane domain are additionally removed. The corresponding plasmids encoding TraG
1 and TraG
2 (Table 1) were unable to restore the transfer activity in complementation experiments with pDB127 (
traG). In contrast, both full-length TraG and His6-TraG were effective in complementing pDB127 (38). We conclude that membrane anchorage of TraG is required for transfer activity.
![]() View larger version (23K): [in a new window] |
FIG. 1. Properties of deletion derivatives of RP4 TraG lacking transmembrane segments. A hydophobicity profile (21) of TraG depicts the hydrophobic regions of the protein. The domain structures of TraG and derivatives TraG 1 and TraG 2 are schematically represented. The transfer activity of each protein is indicated as positive (+) or negative (-). Cytoplasmic domains (open boxes), transmembrane segments (TM1 and TM2) (solid boxes), a periplasmic domain (hatched box), and two nucleotide-binding domains (NBD1 and NBD2) (shaded boxes) are indicated. The sequence of the conserved Walker motif A in NBD1 is given below the diagram, with residue K187 boldfaced. The numbers indicating amino acid (AA) positions at the start of the proteins are the positions relative to the full-length protein.
|
1 and TraG
2 were overproduced and assayed for solubility. Under native conditions, by use of the mild nonionic detergent Brij 58 or Triton X-100, TraG
1 remained insoluble. In contrast, TraG
2 proved to be highly soluble and therefore was selected for purification. The crude extract, containing 42% TraG
2, was purified by successive Ni-NTA affinity and phosphocellulose P11 chromatography, yielding a TraG
2 preparation of 85% purity (Table 2). TraG
2K187T, containing a mutation in the putative nucleotide-binding domain 1 (NBD1) (Fig. 1), was purified similarly (Fig. 2). R388 TrwB
1 is identical to TrwB
N70, whose purification has been described previously (27), except that TrwB
1 carries an N-terminal His6 tag. TrwB
1 was also purified by consecutive Ni-NTA and phosphocellulose P11 chromatography, yielding a TrwB
1 preparation of 97% purity (Fig. 2). |
View this table: [in a new window] |
TABLE 2. Purification of TraG 2, TraG 2K187T, and TrwB 1
|
![]() View larger version (81K): [in a new window] |
FIG. 2. Truncated derivatives of RP4 TraG and R388 TrwB were purified in two steps. Shown are Coomassie blue-stained gels of samples collected during the purification of TraG 2K187T (A) and TrwB 1 (B), resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Lanes 1, marker proteins (sizes in kilodaltons are indicated). Lanes 2, sodium dodecyl sulfate whole-cell extracts (20 µg). Lanes 3 to 5, samples of native protein extracts. Lanes 3, fraction I (17 µg); lanes 4, fraction II (9 µg in panel A and 7 µg in panel B); lanes 5, fraction III (7 µg).
|
2 and TrwB
1, which were characterized in the present study, behaved strictly as monomers in solution (Table 3). Aggregates of full-length TraG were also visualized by electron microscopy of TraG-DNA complexes (Fig. 3). When TraG
2 was analyzed analogously, however, no aggregates were seen and the protein was altogether invisible. Probably a single monomer of TraG
2 was too small to be detected by electron microscopy. Our results indicate that the membrane anchors of TraG and TrwB contain a domain responsible for protein-protein interactions that lead to protein oligomerization or aggregation in vitro. Interactions of TraG derivatives with RP4 relaxase (TraI) were measured with the optical biosensor system Biacore 2000, which uses SPR technology. TraI, TraG
2, and BSA (used as a reference) were immobilized on sensor chip surfaces, and real-time interactions with TraG derivatives were monitored (Fig. 4). TraGK187T interacted with TraI to the same extent as had previously been observed for wild-type TraG (38). As before, association occurred rapidly (ka
105 M-1) and dissociation was slow (Kd
10-4 s-1). In contrast, derivatives TraG
2 and TraG
2K187T did not interact with TraI (shown for TraG
2 in Fig. 4B). Thus, relaxase binding of TraG occurred independently of the nucleotide-binding signature at residue K187 but did require the membrane anchor of TraG. Interaction of full-length TraG with TraG
2 was weak and barely detectable (shown for TraGK187T in Fig. 4A). Also, TraG
2 self-interactions were absent (Fig. 4B). These data are in line with the previous observation that, unlike full-length TraG, TraG
2 is a monomer in solution. |
View this table: [in a new window] |
TABLE 3. Oligomeric states of TraG, TraG 2, and TrwB 1
|
![]() View larger version (128K): [in a new window] |
FIG. 3. Removal of the membrane anchor of TraG suppresses its oligomerization. Shown are electron microscopic images of full-length TraG (A and B) or TraG 2 (C and D) preparations. The proteins were incubated either with ssDNA alone (A and C) or with a 1:1 mixture of ssDNA and dsDNA (B and D) prior to fixation and adsorption to mica. Solid arrowheads, ssDNA molecules; open arrowheads, dsDNA molecules. Large protein oligomers bound to ssDNA were present in TraG preparations (indicated by solid arrows) but absent in TraG 2 preparations.
|
![]() View larger version (23K): [in a new window] |
FIG. 4. Interactions of TraG derivatives with RP4 relaxase (TraI). Complex formation between TraGK187T, TraG 2, and TraI was measured by SPR analysis on sensor chip surfaces. The sensor chip consisted of flow cells containing immobilized TraI (TraI*) or immobilized TraG 2 (TraG 2*). A reference cell with immobilized BSA served as a negative control. Real-time interactions with the immobilized proteins were monitored by injecting 100 nM solutions of TraGK187T (A) or TraG 2 (B) through the flow cells for 4 min. The signals (in response units) were corrected by subtracting the signal obtained from interaction with BSA. The start (0 min) and end (4 min) of injections are indicated by dashed lines delimiting association time (from 0 to 4 min) and dissociation time (from 4 min to infinity).
|
2 and TrwB
1 bind ATP and ADP.
TraG
2 and TrwB
1 were assayed for nucleotide binding by studying the binding of the fluorescent ATP and ADP derivatives TNP-ATP and TNP-ADP. Binding of TNP-nucleotides causes an increase in fluorescence (enhanced fluorescence), a phenomenon that has been widely used to characterize the nucleotide-binding abilities of proteins (20). Fluorescence enhancement emerges from the changes in polarity in the near environment of the TNP moiety upon binding (14, 26). TraG
2 and TrwB
1 produced significant fluorescence enhancement of TNP-ATP and TNP-ADP (Fig. 5). The fluorescence increase was coupled with a blue shift of the fluorescence maximum from 542 to 528 nm, suggesting that the TNP-nucleotides bind to a hydrophobic region of the protein (15). Competition experiments confirmed that nucleotide binding was specific, since addition of an unlabeled nucleotide to TNP-nucleotide-protein complexes considerably reduced the fluorescence (Fig. 5; compare curves 3 with curves 4). In control experiments without protein, TNP-nucleotide fluorescence remained unchanged when either the buffer contained in the used protein solutions or unlabeled nucleotides were added (data not shown).
![]() View larger version (23K): [in a new window] |
FIG. 5. TraG 2 and TrwB 1 bind TNP-ATP. The fluorescent ATP analogue TNP-ATP displayed enhanced fluorescence upon binding by TraG 2 (A) and TrwB 1 (B). Fluorescence spectra 1 to 4 were taken from the following samples: spectrum 1, protein (7 µM); spectrum 2, TNP-ATP (50 µM); spectrum 3, protein (7 µM) plus TNP-ATP (50 µM); spectrum 4, protein (7 µM) plus TNP-ATP (50 µM) in the presence of ATP (10 mM). Fluorescence intensities are expressed in arbitrary units (AU).
|
2 and TrwB
1 with TNP-nucleotides until saturation was observed (shown for TraG
2 in Fig. 6A and B). Saturation of the proteins by TNP-nucleotides is well described by a function that relates fluorescence enhancement (
F) with total TNP-nucleotide concentration, total protein concentration, Kd, and the maximum fluorescence enhancement (equation 3 in Materials and Methods). Computationally fitted Kds for TNP-ATP and TNP-ADP binding of TraG
2 and TrwB
1 were in the 4 to 5 µM range (Table 4).
![]() View larger version (16K): [in a new window] |
FIG. 6. Determination of the Kds for ATP and ADP binding of TraG 2. (A and B) Saturation curves obtained by titration of TraG 2 (7 µM) with TNP-ATP and TNP-ADP, respectively. Binding of TNP-nucleotides was monitored by measuring the fluorescence enhancement, i.e., the difference between the intrinsic TNP-nucleotide fluorescence and the fluorescence of bound TNP-nucleotides. The curves represent the best fit obtained with equation 3 (Materials and Methods), which determined the Kds for TNP-nucleotide binding. (C and D) Displacement of bound TNP-nucleotides by unlabeled nucleotides, causing a decrease in fluorescence. (C) ATP was added to a mixture of TraG 2 (7 µM) and TNP-ATP (50 µM). (D) ADP was added to a mixture of TraG 2 (7 µM) and TNP-ADP (70 µM). The curves were calculated by using equation 4, which contains constants for minimal and maximal fluorescence (Fmin and Fmax). The calculated Kds are listed in Table 4.
|
|
View this table: [in a new window] |
TABLE 4. Kd for binding of ATP, ADP, and fluorescent TNP-nucleotides
|
2 or TrwB
1 with an excess of the respective nucleotide caused a progressive decrease in fluorescence (shown for TraG
2 in Fig. 6C and D). Computational fitting determined the concentration of ATP or ADP that caused 50% dissociation of the TNP-nucleotide-protein complex (IC50), which, in combination with the Kd of TNP-nucleotide binding, provided the Kd for ATP or ADP binding (Table 4). The Kd of nucleotide binding was hereby determined to be in the range of 0.3 to 0.4 mM for TraG
2; nucleotide binding was somewhat stronger for TrwB
1 (Kd, 0.1 to 0.2 mM). Thus, binding of unlabeled nucleotides was significantly lower than binding of fluorescent TNP derivatives (30- to 40-fold lower for TrwB
1 and up to 80-fold lower for TraG
2).
Mutation in the putative nucleotide-binding site of TraG (TraG
2K187T) causes reductions in its ATP- and ADP-binding abilities.
Nucleotide binding of the derivative TraG
2K187T was determined as before, by monitoring the fluorescence enhancement of TNP-ATP and TNP-ADP. The binding of TNP-nucleotides was only slightly weaker than that seen with TraG
2. The Kds were determined to be 6.0 µM for TNP-ATP and 7.2 µM for TNP-ADP. However, displacement of TNP-nucleotides by unlabeled nucleotides revealed that the nucleotide-binding ability of the TraG
2K187T mutant was reduced (Fig. 7). The KdATP (0.81 mM) and KdADP (1.64 mM) indicated 2.4- and 4.5-fold decreases in binding affinity for ATP and ADP, respectively.
![]() View larger version (15K): [in a new window] |
FIG. 7. The TraG 2K187T point mutation derivative has a decreased nucleotide-binding ability. The Kds for ATP and ADP binding of TraG 2K187T were determined by monitoring the displacement of protein-bound TNP-nucleotides by unlabeled nucleotides. Displacement manifested itself as a decrease in fluorescence. (A) ATP was added to a mixture of TraG 2K187T (7 µM) and TNP-ATP (50 µM). (B) ADP was added to a mixture of TraG 2K187T (7 µM) and TNP-ADP (70 µM). The curves were calculated by using the best fit to equation 4 (Materials and Methods), yielding Kds for ATP and ADP binding (Table 4).
|
2 and TrwB
1, Mg2+ had the largest effect (80% reduction in
F). This was also the case for displacement of protein-bound TNP-ADP (data not shown). The Ki for Mg2+ inhibition of TraG
2-TNP-ATP binding was determined to be 82 µM. DNA, especially ssDNA, was also a strong inhibitor for TNP-ATP binding of TrwB
1 but was a much weaker inhibitor for that of TraG
2. All nucleotides and nucleotide derivatives tested were able to compete with TNP-ATP to a certain extent. In the case of TraG
2 binding, ATP itself was the best natural competitor of TNP-ATP, whereas UTP and dTTP were the most effective competitors for TrwB
1 binding. These observations indicated that purine or pyrimidine moieties of nucleotides did not particularly add to the specificity of nucleotide binding of TraG
2 or TrwB
1. The synthetic ATP analogues ATP
S and AppNp were able to displace TNP-ATP to a higher extent than ATP. ADP was a good competitor for both proteins, whereas competition by AMP was poor. Similarly, pyrophosphate (PPi) was a much better competitor than phosphate, although at a lower rate overall than ADP. Thus, there seems to be binding specificity for at least the diphosphate moiety of NTPs or nucleoside diphosphates, whereas purine or pyrimidine moieties are more or less equally well bound and merely add to the strength of binding.
![]() View larger version (30K): [in a new window] |
FIG. 8. Displacement of bound TNP-ATP by other nucleotides, DNA, and inorganic salts. The fluorescence of TNP-ATP-protein mixtures was measured before and after addition of the indicated compounds. The percent fluorescence reduction was set as a measure of the displacement of bound TNP-ATP, i.e., as a measure of competition for the binding site or inhibition of nucleotide binding. Concentrations were as follows: TraG 2 or TrwB 1, 10 µM; TNP-ATP, 50 µM; nucleotides, KxHyPO4, AppNp, Na2SO4, MgSO4, and MgCl2, 5 mM; Na4P2O7 and ATP S, 2.5 mM; ssDNA, 18 nM; dsDNA, 15 nM.
|
2 (Fig. 9). Here, addition of protein to a 0.8-kbp DNA fragment caused a mobility shift of the fragment. Protein-dsDNA complexes did not produce a discrete band but accumulated in the wells of the gel. The apparent Kds (Kdapp) of TraG
2 and TrwB
1 for binding of the 0.8-kb fragment were determined as 75 and 24 nM, respectively. Comparable dsDNA binding affinities were also found for TraG and TraGK187T (data not shown). We conclude that dsDNA binding requires neither the N-terminal membrane anchor nor the conserved residue K187 of the putative nucleotide-binding site.
![]() View larger version (44K): [in a new window] |
FIG. 9. TraG 2 and TrwB 1 bind dsDNA. (A) Fragment shift experiment of TraG 2 and TrwB 1 incubated with a 32P-labeled dsDNA fragment and electrophoresed on a nondenaturing polyacrylamide gel. Addition of increasing amounts of protein (in picomoles) to the 0.8-kb dsDNA fragment (36 fmol) led to accumulation of protein-DNA complexes in the wells of the gel. (B) Bjerrum plot of free DNA as a function of protein concentration. Complex formation with TraG 2 (filled circles) or with TrwB 1 (open circles) was determined by quantifying the fraction of free DNA. The amount of protein necessary to bind half of the DNA was calculated by using the Hill-type equation that describes a symmetrical hyperbola ([A] = 1.5 pmol of TraG 2; [B] = 0.47 pmol of TrwB 1).
|
2) and 1:8.7 (for TrwB
1). Electron microscopy confirmed that ssDNA is the preferred substrate: when equal amounts of ssDNA and dsDNA were incubated with TraG, complexes were formed exclusively with ssDNA (Fig. 3). In contrast, dsDNA-TraG complexes were abundantly seen in the absence of ssDNA (data not shown). Since nucleotide binding of TraG and TrwB was observed to be inhibited by the presence of DNA (see above), we tested whether nucleotides could reversibly inhibit DNA binding. DNA fragment shifts were thus performed in the presence or absence of ATP and ADP. Additionally, the effect of Mg2+ was tested (Fig. 10, lanes 6 to 8 and 14 to 16). With TraG
2, inhibition by Mg2+ was significant (24% complex resolution) but inhibition by ATP and ADP was very low. With TrwB
1, ATP was the strongest inhibitor (37% complex resolution), followed by ADP and Mg2+ (13 and 16% complex resolution, respectively). Thus, inhibition by nucleotides was observed only for TrwB
1, whereas inhibition by Mg2+ applied to both proteins, although at a much lower degree than had been observed in the case of nucleotide binding.
![]() View larger version (43K): [in a new window] |
FIG. 10. Displacement of protein-bound dsDNA by ssDNA, Mg2+, or nucleotides. 32P-labeled dsDNA fragments (75 fmol each) were incubated with TraG 2 (10 pmol) (lanes 1 to 8) or TrwB 1 (3 pmol) (lanes 9 to 16) and then supplemented with a competitor or inhibitor. Complexes were separated from free DNA by electrophoresis on a nondenaturing polyacrylamide gel. DNA fragments (sizes indicated in kilobase pairs) and complexes were visualized by autoradiography. Lanes 1 and 9, protein plus dsDNA; lanes 2 to 5, ssDNA added at 6, 9, 12, and 18 fmol, respectively; lanes 10 to 13, ssDNA added at 3, 6, 9, and 18 fmol, respectively; lanes 6 and 14, MgCl2 (10 mM) added; lanes 7 and 15, ATP (10 mM) added; lanes 8 and 16, ADP (10 mM) added.
|
|
|
|---|
N70) suggested that the cytoplasmic domain of TrwB forms a hexameric channel structure that probably protrudes through the inner membrane (13). The energy for the postulated DNA-protein transport mechanism might be provided by hydrolysis of nucleotides, since sequence analysis identified the family of TraG-like proteins as putative NTPases (23). Genetic experiments have confirmed this view. Amino acid substitutions in the conserved nucleotide-binding motifs, as in the TraG derivatives TraGK187T and TraGD449N, produced a transfer-defective phenotype (2). However, the model lacks definite proof. NTPase assays with four different purified TraG-like proteins failed to detect such an activity (27, 38). A specific conformation or an additional factor may be required for these proteins to induce NTPase activity. Nonetheless, TraG-like proteins were shown, if not to hydrolyze, at least to bind nucleotides (27; this work).
The present study focuses on the nucleotide-binding properties of two TraG-like proteins, TraG and TrwB, and attempts to dissect the multiple functions of TraG. Deletion derivatives lacking the membrane anchor (TraG
2 and TrwB
1) and point mutation derivatives with a mutation in the putative nucleotide-binding site (TraGK187T and TraG
2K187T) were constructed and purified (Fig. 1 and 2). Nucleotide binding was assayed by measuring the fluorescence increase in fluorescent nucleotide derivatives (TNP-nucleotides) upon binding. Apart from binding to ATP, TraG
2 and TrwB
1 were thereby shown to bind ADP (Fig. 5). Compared to TraG
2, mutant TraG
2K187T had a significantly reduced nucleotide-binding ability (Fig. 7), which may account for the transfer-defective phenotype of TraGK187T reported earlier (2). Competition experiments revealed that other NTPs were able to displace protein-bound ATP and that the diphosphate moiety of nucleotides was the core structure required for binding (Fig. 8). The presence of DNA markedly reduced the ATP binding of TrwB
1, and conversely, DNA binding was inhibited by the presence of ATP. This effect was less pronounced with TraG
2, whose DNA-binding capacity was merely lowered by the presence of nucleotides. Both proteins, however, responded strongly to the presence of Mg2+, which significantly inhibited ATP and ADP binding as well as DNA binding (Fig. 8 and 10). Inhibition of ATP binding by Mg2+ (more specifically, inhibition of TNP-ATP binding) has been reported previously for cation pumps KATP (41) and Ca2+-ATPase (28).
Full-length TraG was recently reported to form large oligomers that interact with relaxase, which is an RP4-encoded protein that covalently associates with the nic site of the origin of transfer (32, 38). Analysis of the truncated derivative TraG
2 revealed that removal of its membrane anchor prevented the interaction with relaxase. Gel filtration, electron microscopy, and protein interaction analysis also showed that, unlike TraG, TraG
2 is a monomer in solution (Table 3; Fig. 3 and 4). We conclude that the N-terminal membrane anchor of TraG (residues 1 to 102) is essential for TraG-TraG and TraG-relaxase interactions. Whereas TraG-TraG interactions lead to aggregation in vitro, they are probably important for the self-assembly of TraG in the cell membrane in vivo. Similar conclusions can be drawn from the observations with TrwB. While full-length TrwB forms hexamers, at least partially (16), the truncated derivatives TrwB
N70 and TrwB
1 are strictly monomeric (27) (Table 3). The hexameric nature of TrwB
N70 in its crystal structure, however, indicates that the truncated protein may still form multimers under the restrictive conditions imposed by crystal growth (i.e., high concentration and dehydration).
The failure of TraG
2 to oligomerize may be related to its failure to interact with relaxase. It is indeed conceivable that TraG assembly should occur prior to relaxase binding, since the protein needs first to be properly inserted into the membrane and to build its final putative pore-like architecture before binding to another bulky protein such as relaxase. Another possible explanation for the defect in the relaxase binding of TraG
2 is the assumption that the relaxase-interacting domain is situated in the deleted N terminus. This N terminus consists of a short cytoplasmic tail (residues 1 to 23) followed by a transmembrane segment, a periplasmic domain (residues 44 to 82), and a second transmembrane segment. After exclusion of the transmembrane segments, the periplasmic and cytoplasmic regions of the membrane anchor remain as possible domains for relaxase interaction. Since relaxase is a cytoplasmic protein, the periplasmic domain of TraG is unlikely to play a role in relaxase-interaction. Thus, apart from the possibility that oligomerization of the protein per se is a requirement for relaxase interaction, the short cytoplasmic domain preceding the first membrane segment may be required for this interaction, although it is probably too short to be a domain of its own.
T4SS function as active transporters for delivery of substrates destined for secretion. A question of central interest is how the energy for this transport is provided. Sequence analysis of T4SS-encoded proteins indicated that NTP hydrolysis may be the motor for type IV secretion, since three proteins with putative NTPase activity were identified. Apart from the TraG-like proteins, these include the VirB4-like and the VirB11-like proteins. Each of these proteins is an essential component of the T4SS studied. The proposed NTPase activity was confirmed in vitro for three proteins of the VirB11 family that were also seen to form hexamers (18, 19, 34). Furthermore, the crystal structures of HP0525 (H. pylori) and its nucleotide-bound form suggested a role in the export of substrates and/or in the assembly of the type IV secretion apparatus itself (37, 44). In contrast, purified forms of the VirB4-like proteins TrbE (RP4) and TrwK (R388) were found to lack NTPase activity. However, a mutation in the putative nucleotide-binding site produced a transfer-deficient phenotype (33). The same effect was observed for TraG-like proteins, which equally lack NTPase activity in vitro. Two TraG-like proteins, TraG and TrwB, were now shown to bind ATP as well as ADP, supporting the view that these proteins are somehow involved in an energy-driven transport process fueled by hydrolysis of nucleotides. Comparison of the crystal structures of TrwB
N70 and the protein bound to the ATP analogue AppNp or GppNp has indicated that TrwB undergoes conformational changes upon NTP binding (12). Our results indicate that nucleotide binding of TraG and TrwB is inhibited by Mg2+. In this context, it is worth noting that no Mg2+ ion could be assigned in the structures of AppNp- or GppNp-bound TrwB
N70, although the crystals were purposely grown in the presence of Mg2+. Thus, in agreement with our finding, Mg2+ did not contribute to nucleotide binding in these complexes; rather, the contrary should probably apply. In conclusion, we propose that TraG-like proteins either hydrolyze nucleotides themselves under inducing in vivo conditions that are not fulfilled in vitro or regulate the activity of a different NTPase (such as VirB11) by feeding it with nucleotides and/or discharging the products of hydrolysis. The fact that purified TraG proteins do not hydrolyze nucleoside triphosphates but do bind ATP as well as the product of its hydrolysis, ADP, supports the latter hypothesis. In this mechanism, release and binding of nucleotides could be triggered by Mg2+. Thus, TraG-like proteins, which are known to bind to substrates of type IV secretion, are likely also to be involved in their active export.
In the present work, it was shown that the TraG-like proteins TraG and TrwB bind ATP as well as ADP in the 10-1 mM range and that this binding activity is strongly reduced by Mg2+. Apart from characterizing the nucleotide-binding properties of TraG and TrwB in detail, we have functionally and structurally dissected several of their functions. Removal of the membrane anchor destroyed transfer activity. This was attributed to a defect in protein multimerization and in protein-relaxase interaction. In contrast, the DNA- and nucleotide binding activities of TraG and TrwB were functionally independent of oligomerization or relaxase binding and could be structurally localized to the cytoplasmic C-terminal domain.
We thank Hans Lehrach for generous support. This work was supported by the Deutsche Forschungsgemeinschaft.
|
|
|---|
protein of the Escherichia coli satellite phage P4. J. Biol. Chem. 267:13062-13072.
protein is multifunctional with origin recognition, helicase and primase activities. EMBO J. 12:3703-3708.[Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»